This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diefenbach, C. Articles by Buzello, W. Search for Related Content PubMed PubMed Citation Articles by Diefenbach, C. Articles by Buzello, W.

Greater Neuromuscular Blocking Potency of Atracurium During Hypothermic Than During Normothermic Cardiopulmonary Bypass

University Department of Anesthesiology, Koeln, Germany

Previous studies drew attention to the greater neuromuscular blocking potency of atracurium during, than before or after, hypothermic cardiopulmonary bypass (CPB) while disregarding the periods of normothermic perfusion. We recorded the evoked twitch tension in 15 patients during nitrous oxide/ narcotic anesthesia who were undergoing open heart surgery. Atracurium was injected as an initial bolus dose of 460 µg/kg. Waning neuromuscular blockade was enhanced by repeat injections of 138 µg/kg whenever the twitch tension attained 25% of control. During hypothermic (<32°C) and normothermic (>34°C) CPB, the times of onset of the maintenance doses were 57% and 18% longer, respectively, than before CPB (P < 0.05). Maintenance doses of atracurium were required every 24 ± 4 min (mean ± SD) before CPB, every 45 ± 8 min (P < 0.05) during hypothermia, every 22 ± 3 min during normothermic perfusion, and every 23 ± 3 min after CPB. In conclusion, the patients' changing demand of atracurium paralleled the changes of temperature rather than the institution and cessation of CPB.

This article has been cited by other articles:

				D. J. Cook Changing Temperature Management for Cardiopulmonary Bypass Anesth. Analg., June 1, 1999; 88(6): 1254 - 1254. [Full Text] [PDF]